Skip to main content
SpringerLink
Log in

Endokarditis

  • Chapter
Therapie innerer Krankheiten

  • 22 Accesses

Zusammenfassung

Unbehandelt verläuft die mikrobiell verursachte Endokarditis (IE) letal.Verzögerungen in der Diagnostik und Therapiefehler werden regiehaft mit einer erheblichen Prognoseverschlechterung bezahlt. Eine IE ist bei allen Patienten mit unklarem Fieber oder nachgewiesener Bakteriämie — insbesondere von Streptokokken, Enterokokken und Staphylokokken — oder bei Neuauftreten eines Herzgeräuschs zu vermuten und unverzüglich mittels Echokardiographie abzuklären. Bei vermuteter oder gesicherter IE ist eine enge Kooperation zwischen Kardiologie, Mikrobiologie und Kardiochirurgie unabdingbar. Für die Mehrzahl der heute Erkrankten wird eine chirurgische Intervention noch während der akuten Infektion erforderlich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Burnie JP, Clark J (1995) Immunoblotting in the diagnosis of culture-negative endocarditis caused by streptococci and enterococci. J Clin Pathol 48:1130–1136

    Article  PubMed  CAS  Google Scholar 

  • Bürrig KF, Schulte-Terhausen J, Hort W (1991) Special role of the endocardium in the pathogenis of endocarditis. In: Horstkotte D, Bodnar E (eds) Infective endocarditis. ICR, London, pp 3–9

    Google Scholar 

  • Dajani AS, Bisno AL, Chung KJ et al. (1989) Prevention of rheumatic fever. A statement for health professionals by the Comittee on rheumatic fever and infective endocarditis of the Council on Cardiovascular Disease in the young, the American Heart Association. Pediatr Infect Dis J 8:263–266

    PubMed  CAS  Google Scholar 

  • Goldenberger D, Künzli A, Vogt P, Zbinden R, Altwegg M (1997) Molecular diagnosis of bacterial endocarditis by broad-range PCR amplicfication and direct sequencing. J Clin Microbiol 35: 2733–2739

    PubMed  CAS  Google Scholar 

  • Gruneberg RN, Wilson APR (1996) Dosage recommendations for teicoplanin: what have we learned? Chemother J [Suppl. 5/11]: 13–15

    Google Scholar 

  • Gutschik E (1999) New developments in the treatment of infective endocarditis infective cardiovasculitis. Int J Antimicrob Agents 13:79–92

    Article  PubMed  CAS  Google Scholar 

  • Haas R, Mundinger A, Bohn T, Schaz K, Hunstein W (1985) Therapiemöglichkeiten beim Hypereosinophilie-Syndrom mit Endomyocarditis fibroplastica Löffler. Dtsch Med Wochenschr 41: 1573–1576

    Article  Google Scholar 

  • Hack CE, Ogilvie AC, Eisele B, Erenberg AJM, Wagstaff J, Thijs LG (1993) C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 19: S19–S28

    Article  PubMed  Google Scholar 

  • Horstkotte D (1995) Mikrobiell verursachte Endokarditis. Steinkopff, Darmstadt

    Book  Google Scholar 

  • Horstkotte D, Schulte HD, Bircks W (1991) Factors influencing prognosis and indication for surgical intervention in acute native-valve endocarditis. In: Horstkotte D, Bodnar E (eds) Infective endocarditis. ICR, London, pp 171–197

    Google Scholar 

  • Horstkotte D, Niehues R, Klein RM, Piper C, Schultheiß HP, Schulte HD, Strauer BE (1992) Diagnostische und therapeutische Probleme bei akuter hochgradiger Mitralinsuffizienz. Intensivmedizin 29: 288–297

    Google Scholar 

  • Horstkotte D, Piper C, Niehues R (1994) Prognose und Nachsorge mikrobiell verursachter Endokarditiden. In: Gahl K (Hrsg) Infektiöse Endokarditis. Steinkopff, Darmstadt, S 325–358

    Chapter  Google Scholar 

  • Horstkotte D, and the Task Force on Infective Endocarditis of the European Society of Cardiology (2002) Recommendations for Prevention, Diagnosis and Treatment of Infective Endocarditis. Eur Heart J 23 (in press)

    Google Scholar 

  • Kupferwasser LI, Yeaman MR, Shapiro SM et al. (1999) Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination and fequency of embolism events in experimental staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 99:2791–2797

    Article  PubMed  CAS  Google Scholar 

  • McClosky RV, Straube RC, Sanders C, Smith SM, Smith CR (1994) Treatment of septic shock with human monoclonal antibody HA-1 A: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 121:1–5

    Article  Google Scholar 

  • Meyer T, Reiter H, Mirzaie M, Hasenfuß G, Unterberg C (2000) Symptomatik der primären Endokardfibroelastose im Erwachsenenalter. Dtsch Med Wochenschr 125:168–171

    Google Scholar 

  • Moder KG, Miller TD, Tazelaar HD (1999) Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 74:275–284

    Article  PubMed  CAS  Google Scholar 

  • Mouton JW, Endtz HP, den Hollander JG, van den Braak N, Verbrugh HA (1997) In-vitro activity of quinupristin/daifopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis. J Antimicrob Chemother 39 [Suppl A]: 75–80

    Article  PubMed  CAS  Google Scholar 

  • Murphy PT, Fenelly DF, Stuart M, O’Donnell JR (1990) Alpha-interferon in a case of hypereosinophilic syndrome. Br J Haematol 75: 619–620

    Article  PubMed  CAS  Google Scholar 

  • Myklonakis E, Calderwood SB (2001) Infective endocarditis in adults. N Engl J Med 345:1318–1330

    Article  Google Scholar 

  • Piper C, Wiemer M, Schulte HD, Horstkotte D (2001) Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 10:703–711

    PubMed  CAS  Google Scholar 

  • Raimer LG, Wilson ML, Weinstein MP (1997) Update on detection of bacteremia and fungemia. Clin Microbiol Rev 10:444–465

    Google Scholar 

  • Thomas L, Horstkotte D, Rosin H (1986) Imipenem/GIastatin bei penicillinallergischen Patienten mit Enterokokken-Endokarditis. FAC 5:389–393

    Google Scholar 

  • Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AR, Swanton RH (2002) Mortality from infective endocarditis: clinical predictors of outcome. Heart 88:53–60

    Article  PubMed  CAS  Google Scholar 

  • Washington JA (1989) Blood cultures: An overview. Eur J Clin Microbiol Infect Dis 8:803–806

    Article  PubMed  CAS  Google Scholar 

  • Ziegler EJ, Fisher CJ, Sprung CJ et al. (1991) Treatment of gramnegative bacteremia and septic shock with HA 1A human monoclonal antibody against endotoxin. N Engl J Med 324:429–436

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Horstkotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Wagener
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Piper
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Horstkotte, D., Wagener, J., Piper, C. (2003). Endokarditis. In: Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10475-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10475-0_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10476-7

  • Online ISBN: 978-3-662-10475-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation